Chronic kidney disease (CKD) in children is a devastating illness with long-term effects. Globally the prevalence of CKD in childhood has been variously reported at 15 to 74.7 per million children with an increased burden in developing countries like Bangladesh. The aim of the study was to evaluate the efficacy of Tc-99m MAG3 renal scintigraphy for accurate measurement of DRF and detection of renal cortical scar in comparison to Tc-99m DMSA scan in the pediatric population. This cross-sectional observational study was carried out at the National Institute of Nuclear Medicine & Allied Sciences (NINMAS), BSMMU campus, Dhaka from July 2017 to June 2018. The study was conducted with ethical approval from Medical Research Ethics Committee (MREC). A total of 54 pediatric patients of different renal disorders were enrolled according to selection criteria and all patients underwent both Tc-99m MAG3 renal scintigraphy and Tc-99m DMSA scan by following the practiced protocol in NINMAS. A total of 54 pediatric patients (39 male and 15 female) with a mean age of 4.57 ± 4.40 years, ranging from 0.08 to 18 years had a mean height of 96.70 ± 31.70 cm and mean weight16.97±11.95 kg. The mean of DRF measured by DMSA and MAG3 was 54.22 ±20.38% and S1.47 ± 23.88% in left kidneys and 45.78 ± 20.38% and 48.51 ± 23.88% in right kidneys respectively. The Independent t-test showed the mean difference of DRF measured by two radiotracers was not statistically significant in both kidneys. There was a positive significant correlation between the two methods (Pearson correlation test, r-0.948, p-0.001 in the left kidney and r-0.958, p-0.001 in the right kidney). Our findings support the notion of promoting Tc-99m MAG3 dynamic scintigraphy as an initial nuclear medicine technique in the diagnosis of the majority of kidney illnesses by giving information on differential renal function, cortical anomalies, and drainage at the same time.
Published in | American Journal of Pediatrics (Volume 8, Issue 3) |
DOI | 10.11648/j.ajp.20220803.17 |
Page(s) | 185-190 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2022. Published by Science Publishing Group |
Renal Function, Renal Cortical Scar, Pediatric Population
[1] | Levey, A. S. & Coresh, J. (2012). Chronic kidney disease. The lancet. 379 (9811), 165-180. Available from: doi: 10.1016/S01406736(11)60178-5. |
[2] | Abraham, G., Varughese, S., Thandavan, T., Iyengar, A., Edwin Fernando, E., Naqvi, S. A. J. Sheriff, R., Rashid, H. U., Gopalakrishnan, V. & Kafle, R. K. (2016) Chronic kidney disease hotspots in developing countries in South Asia. Clinical Kidney Journal. 9 (1), 135-141. Available from: doi: 10.1093/ckj/sfv109. |
[3] | Becherucci, F., Roperto, R. M., Materassi, M. & Romagnani, P. (2016) Chronic kidney disease in children. Clinical Kidney Journal. 9 (4), 583-591. Available from: doi: 10.1093/ckj/sfw047. |
[4] | Inoue, Y., Minami, M. & Ohtomo, K. (2004) Isotopic scan for diagnosis of renal disease. Saudi Journal of Kidney Diseases and Transplant. 15 (3), 257-264. |
[5] | Rossleigh, M. A. (2001) Renal cortical scintigraphy and diuresis renography in infants and children. The Journal of Nuclear Medicine. 42 (1), 91-95. |
[6] | Rushton, G. H., & Majd, M. (1992) Dimercaptosuccinie Acid Renal Scintigraphy for The Evaluation of Pyelonephritis and Scarring: A Review of Experimental and Clinical Studies. The journal of urology. 148, 1726-1732. |
[7] | Mandell, G. A., Eggli, D. F., Gilday, D. L. & Heyman, S. (1997) Procedure guideline for renal cortical scintigraphy in children. The Journal of Nuclear Medicine. 38, 1644-1646. |
[8] | Miyazaki, C., Harada, H., Shuke, N., Okizaki, A., Miura. M. & Hirano, T. (2010) 99m Tc-DTPA dynamic SPECT and CT volumetry for measuring split renal function in live kidney donors. Annals of nuclear medicine. 24 (3), 189-195. Available from: doi: 10.1007/s12149-010-0349-y. |
[9] | Fritzberg. A. R., Kasina, S., Eshima, D. & Johnson, D. L. (1986) Synthesis and biological evaluation of technetium-99m MAG3 as a hippuran replacement. Journal of Nuclear Medicine. 27 (1), 111-116. |
[10] | Stakianakis, G. N. & Georgiou, M. F. (1997) MAG3 SPECT: a rapid procedure to evaluate the renal parenchyma. Journal of Nuclear Medicine. 38 (3), 478-83. |
[11] | Abdulrezzak. U.. Erdogan. Z. & Kula, M. (2013) Evaluation of Renal Parenchymal Defects with 99mTechnetium Mercaptoacety ltriglycine Scintigraphy Using a Modified Grading and Scoring System: Comparison with 99mTechnetium Dimercaptosuccinic Acid. Erciyes Medical Journal 35 (1). 18-23. Available from: doi: 10.5152/etd.2013.04. |
[12] | Ritchie, G., Wilkinson, A. G. & Prescott, R. J. (2008) Comparison of differential renal function technetium-99m mercaptoacetyltriglycine (MAG3) and using dimercaptosuccinic acid (DMSA) renography in a paediatric population. Pediatric radiology. 38 (8), 857-862. Available from: https://doi.org/10.1007/s00247-008-0908-8 |
[13] | Smokvina, A., Grbac-Ivankovic, S., Girotto, N., Dezulovic, M. S., Saina, G. & Barkovic, M. M. (2006) The renal parenchyma evaluation: MAG3 vs. DMSA. Collegium antropologicum. 29 (2). 649-54. |
[14] | Othman S, Al-Hawas, A. & Al-Maqtari, R (2012) Renal cortical imaging in children: 99mic MAG3 versus 99mTe DMSA. Clinical nuclear medicine. 37, 351-355. doi: 10.1097/RLU.Ob013e3182443f68. |
[15] | Dostbil, Z., Pembegul, N., Kucukoner, M., Bozkurt, Y., Sancaktutar, A. A., Yildiz, I. & Tekbas, G. (2011) Comparison of split renal function measured by 99mTc-DTPA, 99mTc-MAG3 and 99mTc-DMSA renal scintigraphies in paediatric age groups. Clinical Reviews and Opinions. 32), 20-25. Available from: http://www.academicjournals.org/cro |
[16] | Gad, H. M., Shokeir, A. A. & El-Din, M. (2004) Tc-99m MAG3 dynamic imaging in diagnosis of pyelonephritic changes and renal scarring: a comparative study with Tc-99m DMSA. Abstract only Available from: Journal. 6 (25). Alasbimn http://web.uchile.cl/vignette/borrar2/alasbimn/CDA/sec_c/0, 1222, SCID%253D1 1 137%2526PRT 6253D11128, 00.html |
[17] | Gordon, Anderson, P. J., Lythgoe, M. F. & Orton. M. (1992) Can technetium-99m-mercaptoacetyltriglycine replace technetium99m-dimercaptosuccinic acid in the exclusion of a focal renal defect? Journal of Nuclear Medicine. 33 (12), 2090-2093. |
[18] | Piepsz, A. Pintelon, H., Verboven, M., Keuppens, F. & Jacobs, A. (1992) Replacing 99Tem- DMSA for renal imaging? Nuclear Medicine Communication. 13 (7), 494-6. Available from: 10.1097/0000623 1-199207000-00003. |
[19] | Arroyo, A. J., Semaan, H. B., Minkus, K. D. & Patel, Y. P. (2003) Factors affecting the hepatobiliary excretion of 99mTe MAG3: its clinical significance in routine renography. Journal of Nucearl Medicine Technology 31, 18-20. Available from: http://tech.snmjournals. org/content/3 1/1/18. |
APA Style
Ferdous Ara Begum, Jasmine Ara Haque, Pupree Mutsuddy, Muhammad Zahangir Alam. (2022). Evaluation of MAG3 Renal Scan for Detection of Differential Renal Function and Renal Scar in Comparison to DMSA Scan in Pediatric Population. American Journal of Pediatrics, 8(3), 185-190. https://doi.org/10.11648/j.ajp.20220803.17
ACS Style
Ferdous Ara Begum; Jasmine Ara Haque; Pupree Mutsuddy; Muhammad Zahangir Alam. Evaluation of MAG3 Renal Scan for Detection of Differential Renal Function and Renal Scar in Comparison to DMSA Scan in Pediatric Population. Am. J. Pediatr. 2022, 8(3), 185-190. doi: 10.11648/j.ajp.20220803.17
AMA Style
Ferdous Ara Begum, Jasmine Ara Haque, Pupree Mutsuddy, Muhammad Zahangir Alam. Evaluation of MAG3 Renal Scan for Detection of Differential Renal Function and Renal Scar in Comparison to DMSA Scan in Pediatric Population. Am J Pediatr. 2022;8(3):185-190. doi: 10.11648/j.ajp.20220803.17
@article{10.11648/j.ajp.20220803.17, author = {Ferdous Ara Begum and Jasmine Ara Haque and Pupree Mutsuddy and Muhammad Zahangir Alam}, title = {Evaluation of MAG3 Renal Scan for Detection of Differential Renal Function and Renal Scar in Comparison to DMSA Scan in Pediatric Population}, journal = {American Journal of Pediatrics}, volume = {8}, number = {3}, pages = {185-190}, doi = {10.11648/j.ajp.20220803.17}, url = {https://doi.org/10.11648/j.ajp.20220803.17}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajp.20220803.17}, abstract = {Chronic kidney disease (CKD) in children is a devastating illness with long-term effects. Globally the prevalence of CKD in childhood has been variously reported at 15 to 74.7 per million children with an increased burden in developing countries like Bangladesh. The aim of the study was to evaluate the efficacy of Tc-99m MAG3 renal scintigraphy for accurate measurement of DRF and detection of renal cortical scar in comparison to Tc-99m DMSA scan in the pediatric population. This cross-sectional observational study was carried out at the National Institute of Nuclear Medicine & Allied Sciences (NINMAS), BSMMU campus, Dhaka from July 2017 to June 2018. The study was conducted with ethical approval from Medical Research Ethics Committee (MREC). A total of 54 pediatric patients of different renal disorders were enrolled according to selection criteria and all patients underwent both Tc-99m MAG3 renal scintigraphy and Tc-99m DMSA scan by following the practiced protocol in NINMAS. A total of 54 pediatric patients (39 male and 15 female) with a mean age of 4.57 ± 4.40 years, ranging from 0.08 to 18 years had a mean height of 96.70 ± 31.70 cm and mean weight16.97±11.95 kg. The mean of DRF measured by DMSA and MAG3 was 54.22 ±20.38% and S1.47 ± 23.88% in left kidneys and 45.78 ± 20.38% and 48.51 ± 23.88% in right kidneys respectively. The Independent t-test showed the mean difference of DRF measured by two radiotracers was not statistically significant in both kidneys. There was a positive significant correlation between the two methods (Pearson correlation test, r-0.948, p-0.001 in the left kidney and r-0.958, p-0.001 in the right kidney). Our findings support the notion of promoting Tc-99m MAG3 dynamic scintigraphy as an initial nuclear medicine technique in the diagnosis of the majority of kidney illnesses by giving information on differential renal function, cortical anomalies, and drainage at the same time.}, year = {2022} }
TY - JOUR T1 - Evaluation of MAG3 Renal Scan for Detection of Differential Renal Function and Renal Scar in Comparison to DMSA Scan in Pediatric Population AU - Ferdous Ara Begum AU - Jasmine Ara Haque AU - Pupree Mutsuddy AU - Muhammad Zahangir Alam Y1 - 2022/08/29 PY - 2022 N1 - https://doi.org/10.11648/j.ajp.20220803.17 DO - 10.11648/j.ajp.20220803.17 T2 - American Journal of Pediatrics JF - American Journal of Pediatrics JO - American Journal of Pediatrics SP - 185 EP - 190 PB - Science Publishing Group SN - 2472-0909 UR - https://doi.org/10.11648/j.ajp.20220803.17 AB - Chronic kidney disease (CKD) in children is a devastating illness with long-term effects. Globally the prevalence of CKD in childhood has been variously reported at 15 to 74.7 per million children with an increased burden in developing countries like Bangladesh. The aim of the study was to evaluate the efficacy of Tc-99m MAG3 renal scintigraphy for accurate measurement of DRF and detection of renal cortical scar in comparison to Tc-99m DMSA scan in the pediatric population. This cross-sectional observational study was carried out at the National Institute of Nuclear Medicine & Allied Sciences (NINMAS), BSMMU campus, Dhaka from July 2017 to June 2018. The study was conducted with ethical approval from Medical Research Ethics Committee (MREC). A total of 54 pediatric patients of different renal disorders were enrolled according to selection criteria and all patients underwent both Tc-99m MAG3 renal scintigraphy and Tc-99m DMSA scan by following the practiced protocol in NINMAS. A total of 54 pediatric patients (39 male and 15 female) with a mean age of 4.57 ± 4.40 years, ranging from 0.08 to 18 years had a mean height of 96.70 ± 31.70 cm and mean weight16.97±11.95 kg. The mean of DRF measured by DMSA and MAG3 was 54.22 ±20.38% and S1.47 ± 23.88% in left kidneys and 45.78 ± 20.38% and 48.51 ± 23.88% in right kidneys respectively. The Independent t-test showed the mean difference of DRF measured by two radiotracers was not statistically significant in both kidneys. There was a positive significant correlation between the two methods (Pearson correlation test, r-0.948, p-0.001 in the left kidney and r-0.958, p-0.001 in the right kidney). Our findings support the notion of promoting Tc-99m MAG3 dynamic scintigraphy as an initial nuclear medicine technique in the diagnosis of the majority of kidney illnesses by giving information on differential renal function, cortical anomalies, and drainage at the same time. VL - 8 IS - 3 ER -